Samil Pharm (000520) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.016x

Based on the latest financial reports, Samil Pharm (000520) has a cash flow conversion efficiency ratio of 0.016x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.44 Billion ≈ $1.66 Million USD) by net assets (₩149.26 Billion ≈ $101.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Samil Pharm market capitalisation for the company's overall valuation and market capitalisation.

Samil Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Samil Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Samil Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samil Pharm ranked by their cash flow conversion efficiency. Explore Samil Pharm (000520) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Isik Plastik Sanayi ve Dis Ticaret Pazarlama AS IS:ISKPL	N/A
PT Indonesia Kendaraan Terminal Tbk JK:IPCC	0.066x
DIRTT Environmental Solutions Ltd. TO:DRT	0.036x
Empresas Iansa S.A SN:IANSA	0.111x
Phoenix Tours International Inc TW:5706	-0.001x
Go Hub Capital Berhad KLSE:0311	0.017x
Elektroimportoren As OL:ELIMP	0.079x
X Financial Class A NYSE:XYF	0.190x

Annual Cash Flow Conversion Efficiency for Samil Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samil Pharm from 2012 to 2024. View Samil Pharm (000520) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.12 Billion ≈ $119.36 Million	₩2.59 Billion ≈ $1.76 Million	0.015x	-84.00%
2023-12-31	₩127.83 Billion ≈ $86.63 Million	₩11.75 Billion ≈ $7.96 Million	0.092x	+178.32%
2022-12-31	₩125.82 Billion ≈ $85.27 Million	₩4.15 Billion ≈ $2.82 Million	0.033x	+53.20%
2021-12-31	₩65.75 Billion ≈ $44.56 Million	₩1.42 Billion ≈ $960.19K	0.022x	-82.38%
2020-12-31	₩63.55 Billion ≈ $43.07 Million	₩7.77 Billion ≈ $5.27 Million	0.122x	-28.06%
2019-12-31	₩62.27 Billion ≈ $42.20 Million	₩10.59 Billion ≈ $7.18 Million	0.170x	+463.81%
2018-12-31	₩56.08 Billion ≈ $38.01 Million	₩-2.62 Billion ≈ $-1.78 Million	-0.047x	-163.08%
2017-12-31	₩51.17 Billion ≈ $34.68 Million	₩3.79 Billion ≈ $2.57 Million	0.074x	-30.47%
2016-12-31	₩52.87 Billion ≈ $35.83 Million	₩5.63 Billion ≈ $3.82 Million	0.107x	+98.58%
2015-12-31	₩54.41 Billion ≈ $36.87 Million	₩2.92 Billion ≈ $1.98 Million	0.054x	+124.94%
2014-12-31	₩55.42 Billion ≈ $37.55 Million	₩-11.92 Billion ≈ $-8.08 Million	-0.215x	-277.61%
2013-12-31	₩70.03 Billion ≈ $47.46 Million	₩-3.99 Billion ≈ $-2.70 Million	-0.057x	-171.32%
2012-12-31	₩62.87 Billion ≈ $42.61 Million	₩5.02 Billion ≈ $3.40 Million	0.080x	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$116.53 Million

₩171.96 Billion KRW

Market Cap Rank

#18706 Global

#868 in Korea

Share Price

₩8100.00

Change (1 day)

+2.40%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13